Abiopharma

Law Offices of Howard G. Smith Encourages Integer Holdings Corporation (ITGR) Shareholders To Inquire About Securities Fraud Class Action

VYNE Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of VYNE Therapeutics Inc. is Fair to Shareholders

New Form S-8 - VERU INC. Filed: 2025-12-17 AccNo: 0001437749-25-038096 Size: 228 KB

Director HULL ANDREW 🔴 sold 14 shares (1 derivative) of InMed Pharmaceuticals Inc. (INM) at $1,397.97 Transaction Date: Dec 15, 2025 | Filing ID: 122649

Director ADAMS ERIC A 🔴 sold 250 shares (1 derivative) of InMed Pharmaceuticals Inc. (INM) at $1,397.97 Transaction Date: Dec 15, 2025 | Filing ID: 122647

WOUDENBERG MICHAEL 🔴 sold 60 shares (1 derivative) of InMed Pharmaceuticals Inc. (INM) at $1,397.97 Transaction Date: Dec 15, 2025 | Filing ID: 122645

HSU ERIC C 🔴 sold 70 shares (1 derivative) of InMed Pharmaceuticals Inc. (INM) at $1,397.97 Transaction Date: Dec 15, 2025 | Filing ID: 122641

Law Offices of Frank R. Cruz Encourages Integer Holdings Corporation (ITGR) Shareholders To Inquire About Securities Fraud Class Action

New Form DEFA14A - STAAR SURGICAL CO Filed: 2025-12-17 AccNo: 0001193125-25-322104 Size: 44 KB

📋 Sheena Jonathan (Director) plans to sell 9K shares of Natera, Inc. (at $228.00 each, total $2.1M) Filed: Dec 17, 2025 | ID: 000698

New Study Shows Extended-Release Buprenorphine Safely Delivers Rapid, Clinically Meaningful Reductions in Opioid Use and Supports Abstinence in High-Risk Populations

Incyte Announces European Commission Approval of Minjuvi® (tafasitamab) for the Treatment of Relapsed or Refractory Follicular Lymphoma

(99% Neutral) Nuo Therapeutics, Inc. (AURX) Announces Regulatory Update

STAAR Stockholders Have a Choice: Vote FOR Alcon’s Certain, Premium $30.75 Per Share Cash Offer or Bear the Downside Risk that Broadwood Has No Credible Plan to Create Stockholder Value

New Form 10-K - VERU INC. Filed: 2025-12-17 AccNo: 0001437749-25-038089 Size: 9 MB